研究单位：[1]Capital Medical University[2]Xuanwu Hospital,Capital Medical University Beijing,Beijing,China,100053
研究目的：
The primary objective of the study will be to determine whether rapid remote limb ischemic preconditioning (RIPC) combined with acetazolamide can further reduce the incidence of acute mountain sickness (AMS) during the 6-hour hypoxic chamber.
